Jump to content

Search the hub

Showing results for tags 'Long Covid'.

More search options

  • Search By Tags

    Start to type the tag you want to use, then select from the list.

  • Search By Author

Content Type


Forums

  • All
    • Commissioning, service provision and innovation in health and care
    • Coronavirus (COVID-19)
    • Culture
    • Improving patient safety
    • Investigations, risk management and legal issues
    • Leadership for patient safety
    • Organisations linked to patient safety (UK and beyond)
    • Patient engagement
    • Patient safety in health and care
    • Patient Safety Learning
    • Professionalising patient safety
    • Research, data and insight
    • Miscellaneous

Categories

  • Commissioning, service provision and innovation in health and care
    • Commissioning and funding patient safety
    • Digital health and care service provision
    • Health records and plans
    • Innovation programmes in health and care
    • Climate change/sustainability
  • Coronavirus (COVID-19)
    • Blogs
    • Data, research and statistics
    • Frontline insights during the pandemic
    • Good practice and useful resources
    • Guidance
    • Mental health
    • Exit strategies
    • Patient recovery
    • Questions around Government governance
  • Culture
    • Bullying and fear
    • Good practice
    • Occupational health and safety
    • Safety culture programmes
    • Second victim
    • Speak Up Guardians
    • Staff safety
    • Whistle blowing
  • Improving patient safety
    • Clinical governance and audits
    • Design for safety
    • Disasters averted/near misses
    • Equipment and facilities
    • Error traps
    • Health inequalities
    • Human factors (improving human performance in care delivery)
    • Improving systems of care
    • Implementation of improvements
    • International development and humanitarian
    • Safety stories
    • Stories from the front line
    • Workforce and resources
  • Investigations, risk management and legal issues
    • Investigations and complaints
    • Risk management and legal issues
  • Leadership for patient safety
    • Business case for patient safety
    • Boards
    • Clinical leadership
    • Exec teams
    • Inquiries
    • International reports
    • National/Governmental
    • Patient Safety Commissioner
    • Quality and safety reports
    • Techniques
    • Other
  • Organisations linked to patient safety (UK and beyond)
    • Government and ALB direction and guidance
    • International patient safety
    • Regulators and their regulations
  • Patient engagement
    • Consent and privacy
    • Harmed care patient pathways/post-incident pathways
    • How to engage for patient safety
    • Keeping patients safe
    • Patient-centred care
    • Patient Safety Partners
    • Patient stories
  • Patient safety in health and care
    • Care settings
    • Conditions
    • Diagnosis
    • High risk areas
    • Learning disabilities
    • Medication
    • Mental health
    • Men's health
    • Patient management
    • Social care
    • Transitions of care
    • Women's health
  • Patient Safety Learning
    • Patient Safety Learning campaigns
    • Patient Safety Learning documents
    • Patient Safety Standards
    • 2-minute Tuesdays
    • Patient Safety Learning Annual Conference 2019
    • Patient Safety Learning Annual Conference 2018
    • Patient Safety Learning Awards 2019
    • Patient Safety Learning Interviews
    • Patient Safety Learning webinars
  • Professionalising patient safety
    • Accreditation for patient safety
    • Competency framework
    • Medical students
    • Patient safety standards
    • Training & education
  • Research, data and insight
    • Data and insight
    • Research
  • Miscellaneous

News

  • News

Find results in...

Find results that contain...


Date Created

  • Start
    End

Last updated

  • Start
    End

Filter by number of...

Joined

  • Start

    End

Group

First name

Last name

Country

Join a private group (if appropriate)

About me

Organisation

Role

Found 454 results
  1. News Article
    People who are vaccinated are less likely to develop Long Covid even if they catch the virus, a rapid review by the UK Health Security Agency reveals. It looked at the available evidence to date from 15 studies around the world. The findings suggest that while some who are jabbed catch Covid, vaccines reduce infection risk and illness, including symptoms like fatigue. And unvaccinated people who catch Covid and get symptoms of Long Covid, do better if they then get vaccinated. Vaccine effectiveness against most Long-Covid symptoms was highest in people aged 60 years and over In people who already had Long Covid symptoms, it found that vaccines may improve rather than worsen Covid symptoms, either immediately or over several weeks According to the UK Health Security Agency (UKHSA), around 2% of the UK population have reported symptoms of Long Covid, such as fatigue, shortness of breath and muscle or joint pain. Symptoms like these can last for more than four weeks after the infection. Read full story Source: 15 February 2022
  2. Content Article
    The UK Health Security Agency (UKHSA) has undertaken a rapid evidence review looking at the effects of vaccination against Long COVID or post-COVID symptoms. The review includes 15 UK and international studies that were undertaken up until January 2022. An estimated 2% of the UK population have reported symptoms of long COVID or post-COVID syndrome, which can last for more than 4 weeks after their initial infection. The three most common symptoms are fatigue, shortness of breath and muscle or joint pain. Eight of the studies in the review looked at the effect of vaccinations administered before infection. Most of these studies suggest that vaccinated people (1 or 2 doses) were less likely to develop symptoms of long COVID following infection compared with unvaccinated people – in the short term and long term (4 weeks up until 6 months after infection).
  3. News Article
    Even a mild case of COVID-19 can increase a person’s risk of cardiovascular problems for at least a year after diagnosis, a new study1 shows. Researchers found that rates of many conditions, such as heart failure and stroke, were substantially higher in people who had recovered from COVID-19 than in similar people who hadn’t had the disease. What’s more, the risk was elevated even for those who were under 65 years of age and lacked risk factors, such as obesity or diabetes. “It doesn’t matter if you are young or old, it doesn’t matter if you smoked, or you didn’t,” says study co-author Ziyad Al-Aly at Washington University in St. Louis, Missouri, and the chief of research and development for the Veterans Affairs (VA) St. Louis Health Care System. “The risk was there.” People who had recovered from COVID-19 showed stark increases in 20 cardiovascular problems over the year after infection. For example, they were 52% more likely to have had a stroke than the contemporary control group, meaning that, out of every 1,000 people studied, there were around 4 more people in the COVID-19 group than in the control group who experienced stroke. The risk of heart failure increased by 72%, or around 12 more people in the COVID-19 group per 1,000 studied. Hospitalization increased the likelihood of future cardiovascular complications, but even people who avoided hospitalization were at higher risk for many conditions. “I am actually surprised by these findings that cardiovascular complications of COVID can last so long,” Hossein Ardehali, a cardiologist at Northwestern University in Chicago, Illinois, wrote in an e-mail to Nature. Because severe disease increased the risk of complications much more than mild disease, Ardehali wrote, “it is important that those who are not vaccinated get their vaccine immediately”. Read full story Source: Nature, 10 February 2022
  4. Content Article
    As the impact of Long Covid is still very new and we are continuing to learn more about the condition every day, these NHS guidelines have been drafted to help our NHS line managers and leaders understand what Long Covid is and how they can support colleagues who are experiencing its symptoms. These guidelines include information about what Long Covid is, advice on HR elements such as sick pay and how to record Long Covid-related absence, as well as practical tips on the benefits of having regular health and wellbeing conversations with your teams to talk about Long Covid and reasonable adjustments that might need to be made to support colleagues to return to work. 
  5. News Article
    Staff on prolonged sick leave due to long covid could be dismissed if ‘redeployment is not an option’ and they are unable to fulfil their contract, new NHS England guidance says. The advice was set out in guidance published this month and follows the government’s temporary, non-contractual guidance that was issued in response to the coronavirus pandemic during its first waves. The government’s advice aimed to provide a temporary enhancement of covid sick pay and meant that staff who were absent with covid would remain on full pay, therefore, did not feel pressured to return. However, NHSE’s guidance warned that “while this provision is still available, it is possible that it may change”. The move has been seen as an inevitable step as the guidance was brought in as an emergency measure, while some employers may have been holding off dismissing staff with long covid or covid-related absences due to guidelines in place. NHSE’s new Guidelines for supporting our NHS people affected by long covid said: “According to [the] guidance, periods of covid-19 sick pay would not be counted towards a colleague’s normal sickness entitlements. “However, if a colleague is approaching long-term sickness (for a period of 12 months or more), the employing organisation would be expected to complete a review at 12 months to understand the ongoing need and potential challenges with a return to work. It adds: “Consideration of dismissal due to the colleague being unable to fulfil their contract should only be considered if redeployment is not an option.” Read full story (paywalled) Source: HSJ, 11 February 2022
  6. Content Article
    This report from CIPD examines the latest evidence and the experiences of employees experiencing long COVID, and offers recommendations for organisations on how to effectively support those with long COVID to return to, and stay in, work.
  7. Event
    until
    The session will focus on the patient experience of Long Covid and will talk about what people with the illness would like from healthcare. It will then look at what we know so far in terms of support plans. The workshop will be presented by Margaret O’Hara, a research professional in the NHS who has Long Covid and Dr Elaine Maxwell, a former Scientific Advisor to the National Institute for Health Research. Margaret runs a Facebook page to promote involvement, participation and engagement in Covid research and is a founding Trustee of the charity Long Covid Support, while Dr Maxwell has authored two dynamic reviews on Long Covid and is a Trustee of Long Covid Support. Register
  8. Event
    By joining this session, you will be able to take away information and guidelines on how to support the wellbeing of our NHS people who are affected by Long Covid. The session will be run by our fantastic speakers covering a range of key topics, including: An introduction to Long Covid. Guidelines for supporting our NHS people affected by Long Covid. Exploring Long Covid through wellbeing conversations. Register
  9. Content Article
    This self-assessment tool has been developed by the British Lung Foundation for people with Long Covid symptoms. It aims to help patients identify and prioritise their needs, signposts them to further information and outlines the help they should get in dealing with Long Covid. It is anonymous and takes 5-10 minutes to complete. Patients can also print out their answers and share them with healthcare professionals an employers to clearly highlight an individual's needs.
  10. News Article
    It is one of many mysteries about Long Covid: Who is more prone to developing it? Are some people more likely than others to experience physical, neurological or cognitive symptoms that can emerge, or linger for, months after their coronavirus infections have cleared? Now, a team of researchers who followed more than 200 patients for two to three months after their Covid diagnoses report that they have identified biological factors that might help predict if a person will develop long Covid. The study, published by the journal Cell, found four factors that could be identified early in a person’s coronavirus infection that appeared to correlate with increased risk of having lasting symptoms weeks later: The level of coronavirus RNA in the blood early in the infection, an indicator of viral load. The presence of certain autoantibodies — antibodies that mistakenly attack tissues in the body as they do in conditions like lupus and rheumatoid arthritis. The reactivation of Epstein-Barr virus, a virus that infects most people, often when they are young, and then usually becomes dormant. Having Type 2 diabetes, although the researchers and other experts said that in studies involving larger numbers of patients, it might turn out that diabetes is only one of several medical conditions that increase the risk of Long Covid. The researchers said they had found that there was an association between these factors and Long Covid whether the initial infection was serious or mild. They said that the findings might suggest ways to prevent or treat some cases of Long Covid, including the possibility of giving people antiviral medications soon after an infection has been diagnosed. “I think this research stresses the importance of doing measurements early in the disease course to figure out how to treat patients, even if we don’t really know how we’re going to use all that information yet,” said Jim Heath, the principal investigator of the study. However, the study authors and other experts cautioned that the findings were exploratory and would need to be verified by considerably more research. Read full story (paywalled) Source: The New York Times, 25 January 2022
  11. Content Article
    Infographic from Long Covid Kids & Friends on the obstacles and challenges families, children and young people with Long Covid face.
  12. Content Article
    Symptoms involving almost every organ system have been reported after SARS-CoV-2 infection. Estimates of the prevalence of long covid (also called post-covid-19 condition, post-acute sequelae of covid-19, or chronic covid syndrome) vary considerably, partly because of confusion around the definition. The term long covid encompasses a broad range of symptoms, including objective complications of covid-19 (pulmonary fibrosis, myocardial dysfunction), mental health conditions, and more subjective, non-specific symptoms resembling those seen in post-viral chronic fatigue syndrome (myalgic encephalomyelitis). Most studies to date have substantial limitations, including small cohorts, absence of control groups, non-standardised capture of symptoms, lack of correction for pre-existing medical conditions, participant reported infection, and variation in follow-up, as well as selection, non-response, misclassification, and recall biases. In children and adolescents, acute Covid-19 is less severe than in adults. Concern among many parents has therefore focused more on the potential long term effects of SARS-CoV-2 infection. Unfortunately, fewer data are available on long covid in young people compared with adults.
  13. News Article
    Doctors have discovered an “antibody signature” that can help identify patients most at risk of developing long Covid, a condition where debilitating symptoms of the disease can persist for many months. Researchers at University hospital Zurich analysed blood from Covid patients and found that low levels of certain antibodies were more common in those who developed long Covid than in patients who swiftly recovered. When combined with the patient’s age, details of their Covid symptoms and whether or not they had asthma, the antibody signature allowed doctors to predict whether people had a moderate, high or very high risk of developing long-term illness. “Overall, we think that our findings and identification of an immunoglobulin signature will help early identification of patients that are at increased risk of developing long Covid, which in turn will facilitate research, understanding and ultimately targeted treatments for long Covid,” said Onur Boyman, a professor of immunology who led the research. Read full story (paywalled) Source: The Guardian, 25 January 2022
  14. News Article
    NHS trusts in England lost nearly 2m days in staff absences due to long Covid in the first 18 months of the pandemic, according to figures that reveal the hidden burden of ongoing illness in the health service. MPs on the all-party parliamentary group (APPG) on coronavirus estimate that more than 1.82m days were lost to healthcare workers with long Covid from March 2020 to September 2021 across England’s 219 NHS trusts. The estimate is based on data obtained under the Freedom of Information Act from 70 NHS trusts and does not include the impact of the highly transmissible Omicron variant that has fulled record-breaking waves of infection in the UK and globally since it was first detected in November. Layla Moran, the Liberal Democrat MP who chairs the APPG, said the government had paid “almost no attention to long Covid and the severe impact it was having on vital public services” and called for immediate support for those affected. “Thousands of frontline workers are now living with an often debilitating condition after being exposed to the virus while protecting this country,” she said. “They cannot now be abandoned.” Read full story Source: The Guardian, 24 January 2022
  15. News Article
    Researchers at the University of Derby and their regional, national and international partners are working collaboratively to develop bespoke support pathways for patients with Long Covid. Led by Dr Mark Faghy, they are currently running a series of projects to understand the determinants of recovery which captures the lived experience and informs a bigger piece of work to develop a holistic view of the key stakeholders that are required to develop pathways that can improve patient outcomes. One part of this is the launch of a new Delphi Consensus statement which seeks to obtain input from patients, researchers and any healthcare professionals to inform the approaches to support people living with long COVID. If you have an interest in this study, please click here. For more information on the current work, please contact Dr Mark Faghy (@DrMark_Faghy and M.Faghy@Derby.ac.uk) and also see: https://www.derby.ac.uk/news/2022/international-trial-aims-to-improve-the-quality-of-life-for-long-covid-patients/ “
  16. Content Article
    'Support after Covid-19' is a series of short podcasts exploring Long Covid and work. It was developed by Professor Cathy Bulley and Dr Eleanor Curnow at Queen Margaret University in response to research insights from the ‘Support After Covid Study,’ which was carried out between May 2020 and June 2021. It focuses on the experiences of people working in health services who are living with Long Covid, offering resources, insight and advice.
  17. Event
    until
    The next NHS England and NHS Improvement wellbeing community event, hosted by the People Directorate and facilitated by NHS Horizons will be focusing on: ‘Supporting our NHS People affected by Long Covid’ By joining this session, you will be able to take away information and guidelines on how to support the wellbeing of our NHS people who are affected by Long Covid. Register
  18. Content Article
    South Wales pharmacist, Geraint Jones, contracted COVID-19 in April 2020. He shares an insight to his experiences over the last year after he was later diagnosed with Long Covid.
  19. Content Article
    In this interview for Woman's Hour, Dr Nisreen Alwan, Associate Professor in Public Health at the University of Southampton, discusses the impact of Long Covid on her own life with presenter Emma Barnett. She also shares insights from research that suggests women, people of working age, people from areas of high social deprivation and frontline health and education workers are more likely to be affected by Long Covid. Dr Alwan talks about the need to manage Long Covid alongside daily activities and highlights new research that demonstrates that vaccines may reduce the incidence of the condition. The interview can be heard at 17:23-25:20 in the recording.
  20. Event
    until
    Six months on from the Royal Society of Medicine's first Spotlight on long COVID, this second episode will look at the current prevalence and cases of long COVID, how our understanding of symptoms and treatments has moved on, and the challenges around access to care. This episode will: Advise health professionals on how to continue managing and supporting patients with long COVID using the latest research and treatments Showcase how long COVID has impacted children and young people Discuss the challenges and solutions around access to care, and rising referral rates to long COVID clinics Address the various barriers that different population groups like minority ethnic communities are facing around long COVID Find out how healthcare workers are being affected by long COVID e.g. morale, workforce turnover, wellbeing Understand how other countries are coping with long COVID and what they are doing differently to the UK Register
  21. News Article
    About 1.3 million people in the UK have Long Covid symptoms lasting more than four weeks after an initial infection, an Office for National Statistics survey suggests. Of those, 892,000 (70%) first caught the virus at least 12 weeks ago and 506,000 (40%) at least a year ago. The survey asked nearly 352,000 people to record their own symptoms. There is no universally agreed definition of long Covid and different studies use varying definitions. The ONS survey, over four weeks in November and December 2021, suggests, of those with Long Covid: 51% have fatigue 37% have loss of smell 36% have shortness of breath 28% have difficulty concentrating. University of Exeter senior clinical lecturer Dr David Strain said: "The stark warning here is that, based on this, in the previous waves, over 800,000 people have their day-to-day activities significantly affected over three months after catching Covid and nearly a quarter of a million report this has a dramatic impact on their quality of life. "As we continue to see case numbers of Omicron rise, we must be wary that our reliance purely on hospitalisations and death as a measure of the risk from Covid could grossly underestimate the public-health impact of our current Covid strategy." Read full story Source: BBC News, 6 January 2022
  22. Content Article
    In this interview with the journal International Politics and Society, Brendan Delaney, professor at the Faculty of Medicine at Imperial College London discusses the impact of Long Covid on individuals and society. He describes his own experience of Long Covid, which rendered him unable to work for months, and highlights that we should not be surprised by the prevalence of Long Covid, as all epidemics result in long-term illness for many people. He draws attention to parts of the political system 'not believing in' Long Covid and highlights the damage caused by psychologising the condition. Finally, he points to the need for more research to better understand Long Covid symptoms.
  23. Content Article
    In the wake of new variants and the relentless spread of Covid-19, understanding the complex nature of Long Covid is crucial. In this article, I aim to present useful information on the risk factors, plausible pathophysiological mechanisms and treatment of Long Covid. The obscure nature of Long Covid is a conundrum both for doctors and patients. To mitigate the burden of Long Covid, early identification of disease signs, appropriate treatment and timely access to rehabilitation care is vital. I believe that strengthening the 4 Rs (Reporting, Recognition, Rehabilitation and Research) through close collaboration between government organisations, pharmaceutical industries, patients and health care providers could reduce the impact of Long Covid.
  24. Content Article
    By autumn 2021 there could be more people suffering from Long COVID in the UK than from dementia. How can healthcare services cope with this serious challenge – a condition which can include multi-organ damage, clotting problems, disordered immune response, and renal, liver and brain issues, yet remains little understood? Dr Elaine Maxwell of the National Institute for Health Research tells us how the NIHR’s Long COVID report uncovered a growing and complex problem, and discovered that the largest group of sufferers are working age women in healthcare – AKA nurses.
  25. Content Article
    COVID-19 is known to cause multi-organ dysfunction in acute infection, with prolonged symptoms experienced by some patients, termed Post-Acute Sequelae of SARSCoV-2 (PASC). However, the burden of infection outside the respiratory tract and time to viral clearance is not well characterised, particularly in the brain. Chertow et al. performed complete autopsies on 44 patients with COVID-19 to map and quantify SARS-CoV-2 distribution, replication, and cell-type specificity across the human body, including brain, from acute infection through over seven months following symptom onset. The study showed that SARS-CoV-2 is widely distributed, even among patients who died with asymptomatic to mild COVID-19, and that virus replication is present in multiple pulmonary and extrapulmonary tissues early in infection. The authors detected persistent SARS-CoV-2 RNA in multiple anatomic sites, including regions throughout the brain, for up to 230 days following symptom onset. Despite extensive distribution of SARS-CoV-2 in the body, the authors observed a paucity of inflammation or direct viral cytopathology outside of the lungs. The data prove that SARS-CoV-2 causes systemic infection and can persist in the body months. * Note: This is a pre-print and has not been peer-reviewed yet.
×
×
  • Create New...